An analysis article compared two healthcare ETFs. FHLC tracks a broad range of U.S. healthcare stocks, has lower fees than PJP, and offers a higher dividend yield, with over 300 stock holdings, making it more diversified. PJP, on the other hand, focuses on pharmaceutical companies, holding 33 stocks, and has outperformed FHLC in total returns over the past one to five years, but has higher fees and more concentrated risk. The article suggests that investors should choose based on their own objectives, weighing costs, diversification, and return performance.